Svmuu News: According to informed sources, blockchain payment company Ripple has initiated a share buyback plan of up to $7.5 billion, valuing the entire company at approximately $50 billion.
The buyback will be conducted through a tender offer, allowing investors and company employees to sell their shares back to the company. This buyback plan is expected to last until April this year. Bloomberg was the first to report this news.
This buyback plan follows Ripple's attempt in October last year to repurchase $1 billion in shares at a $40 billion valuation. At that time, participation was relatively limited as some private equity shareholders were unwilling to sell their shares.
Ripple's most recent financing occurred in November last year, when the company completed a $500 million strategic financing round, also at a $40 billion valuation. That round was led by funds related to Fortress Investment Group and Citadel Securities, with participation from institutions such as Pantera Capital, Galaxy Digital, Brevan Howard, and Marshall Wace.
Ripple President Monica Long stated earlier this year that the company currently has no plans for an IPO and emphasized that Ripple's financial situation is robust, preferring to continue expansion through mergers and acquisitions and product development.
Ripple Launches $7.5 Billion Share Buyback, Company Valuation Reaches $50 Billion
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
5
Israeli West Bank Settler Tells BBC Attacks on Palestinians Are Justified as Revenge, Equating One Jewish Life to "10 Million" Palestinians
-
6
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
9
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
10
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
Markets Today
Recommended Reading






